Suchergebnisse - "Ruffo, Giovan Battista"

PubPharm (29)

1

Nephrological Complications in Hemoglobinopathies : SITE Good Practice

enthalten in: Journal of clinical medicine | 2023

von Ruffo, G. | Russo, R. | Casini, T. | +10

2

Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection

enthalten in: American journal of hematology | 2022

von Longo, F. | Gianesin, B. | Voi, V. | +51

3

Non-transfusion-dependent thalassemia in Italy : less blues, no role of reds

enthalten in: Annals of hematology | 2022

von Tartaglione, I. | Manara, R. | di Concilio, R. | +8

CommentOn: Ann Hematol. 2020 Apr;99(4):903-904. - PMID 32086585

4

Italian patients with hemoglobinopathies exhibit a 5‐fold increase in age‐standardized lethality due to SARS‐CoV‐2 infection

enthalten in: American Journal of Hematology | 2022

von Longo, F. | Gianesin, B. | Voi, V. | +51

5

Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds

enthalten in: Annals of hematology | 2021

von Tartaglione, I. | Manara, R. | di Concilio, R. | +8

6

Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds

enthalten in: Annals of hematology | 2021

von Tartaglione, I. | Manara, R. | di Concilio, R. | +8

7

Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds

enthalten in: Annals of hematology | 2021

von Tartaglione, I. | Manara, R. | di Concilio, R. | +8

8

Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study

enthalten in: Experimental hematology & oncology | 2020

von Tartaglione, I. | Origa, R. | Kattamis, A. | +6

9

Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study

enthalten in: Experimental hematology & oncology | 2020

von Tartaglione, I. | Origa, R. | Kattamis, A. | +6

10

Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS : phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study

enthalten in: Experimental hematology & oncology | 2020

von Tartaglione, I. | Origa, R. | Kattamis, A. | +6